Makers Of Impotence Drugs Fined $1M

Law360, New York (March 4, 2008, 12:00 AM EST) -- A federal judge ordered a Florida drugmaker to pay roughly $1 million in penalties for misbranding and marketing its erectile dysfunction products without regulatory approval.

Judge Mary Lisi of the U.S. District Court for Rhode Island fined White Broadman Inc. more than $794,000 on Friday. In addition, the judge fined the company's president, James Mienik, $205,000, and he and part-owner Paul Romano received one year of probation for marketing the Penetrex and Penetrin drugs.

Federal prosecutors began the case in October 2007, accusing White Broadman of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.